Whitfield Dianne C. 4

What Happened
Dianne C. Whitfield, Chief Human Resources Officer of Tarsus Pharmaceuticals (TARS), reported three open-market/private sales (code S) tied to the settlement of restricted stock units. She sold 4,029 shares on 2026-03-17 at $69.42 for $279,693; 4,071 shares on 2026-03-18 at $68.71 for $279,718; and 4,174 shares on 2026-03-19 at $67.00 for $279,658 — a total of 12,274 shares and $839,069 in proceeds. These were sell-to-cover transactions to satisfy tax withholding obligations, not discretionary investment sales.

Key Details

• Transaction dates and prices:
  • 2026-03-17 — 4,029 shares @ $69.42 ($279,693)
  • 2026-03-18 — 4,071 shares @ $68.71 ($279,718)
  • 2026-03-19 — 4,174 shares @ $67.00 ($279,658)
• Total: 12,274 shares; total proceeds $839,069; weighted average price ≈ $68.34/share.
• Shares owned after the transactions: Not disclosed in the provided Form 4 details.
• Footnote: F1 — sales were "sell-to-cover" mandated by the issuer to fund tax withholding on RSU vesting/settlement (not discretionary trades by the insider).
• Timeliness: Filed 2026-03-19 for transactions from 2026-03-17–03-19; filing appears timely under Form 4 rules.

Context
Sell-to-cover transactions are common when restricted stock units vest: the company (or broker) sells enough shares to cover the employee’s tax bill. Such sales are administrative and generally should not be interpreted as a personal bearish signal from the insider.